MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-24-0029163
Prism Pharma (India) Private Limited
Prism Pharma (India) Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.4 Cr
▼ 13% YoY
Net loss · FY 2025
₹5.92 Lakh
Net margin -4.2%
EBITDA · FY 2025
₹1.78 Lakh
EBITDA margin 1.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1.46 Cr
Satisfied ₹2.42 Lakh
Company age
24 yrs
Est. 2002
Directors on board
2
As per MCA filings
About Prism Pharma (India) Private Limited
Data last updated:
Prism Pharma (India) Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2002PTC049597. Its GSTIN is 33AAECA9288R1ZU (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Ramalingam Lakshmi and Ramalingam Jayaram.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1257/3 Golden Colonymogappair Chennai 600 050, Tamil Nadu, India – 600050.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.4 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹5.92 Lakh (net margin -4.2%) and EBITDA of ₹1.78 Lakh (EBITDA margin 1.3%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹1.46 Cr and satisfied charges of ₹2.42 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it.
Prism Pharma (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0029163). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24231TN2002PTC049597
Registration Number 049597
Incorporation Date 13 September 2002
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-24-0029163
Recognitions & Rankings of Prism Pharma (India)
Contact details
Prism Pharma (India) Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1257/3 Golden Colonymogappair Chennai 600 050, Tamil Nadu, India – 600050
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Prism Pharma (India) Private Limited, buy the company report.
Comprehensive company report
Prism Pharma (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Prism Pharma (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Prism Pharma (India) Private Limited, buy the company report.
Financials of Prism Pharma (India) Private Limited
FY 2025 filings availablePrism Pharma (India) Private Limited reported revenue of ₹1.4 Cr (down 13% YoY) for FY 2025.
Revenue · FY 2025
₹1.4 Cr ▼ 13%
Net loss · FY 2025
₹5.92 Lakh margin -4.2%
EBITDA · FY 2025
₹1.78 Lakh margin 1.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 7%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▲ 159%
3 years · compounded
▼ 22%
5 years · compounded
▼ 25%
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 13% fall in the latest year. EBITDA rose 159% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | -4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prism Pharma (India) Private Limited, buy the company report.
Board of directors of Prism Pharma (India) Private Limited
Prism Pharma (India) has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramalingam Lakshmi | Director | 13 Sep 2002 | 24 Years 1 Months | Current |
| Ramalingam Jayaram | Director | 21 Sep 2017 | 9 Years 1 Months | Current |
Peer comparison
Prism Pharma (India) Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ambrosia Remedies Pvt Ltd | ₹1.41 Cr (FY 2017) | 12.0% | Vadodara, Gujarat, India | |||
| Kalpasthana Life Care Products Private Limited | ₹1.4 Cr (FY 2024) | 692.0% | Humnabad, Karnataka, India | |||
| Prism Pharma (India) Private Limitedthis company | ₹1.4 Cr (FY 2025) | -₹5.92 Lakh | -4.2% | -13.0% | Chennai, Tamil Nadu, India | |
| Cureford Healthcare Private Limited | ₹1.39 Cr (FY 2023) | -39.0% | Rudrapur, Uttarakhand, India | |||
| Vibrant Pharmacuticals Private Limited | ₹1.39 Cr (FY 2025) | 16.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Prism Pharma (India) Private Limited, buy the company report.
Auditor
Prism Pharma (India) Private Limited is audited by R.GOPALAKRISHNAN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.GOPALAKRISHNAN & CO | FY 2023 | 000972S |
Shareholding
The shareholding of Prism Pharma (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Prism Pharma (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.46 Cr
Satisfied charges
₹2.42 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2022 | 100692110 | Hdfc Bank Limited | ₹9 Lakh | Open | |
| 16 Sep 2020 | 100376482 | State Bank of India | ₹5.88 Lakh | Open | |
| 09 Aug 2004 | 90286152 | State Bank of India | ₹29.2 Lakh | Open | |
| 09 Aug 2004 | 90302912 | State Bank of India | ₹1.01 Cr | Open | |
| 07 Oct 2005 | 90289676 | Sundaram Finance Limited | ₹2.42 Lakh | Satisfied |
To see the full charge records of Prism Pharma (India) Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Prism Pharma (India) Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Total cases
3
Filed against the company
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Wallace Pharmaceuticals Pvt. Ltd. | Disposed |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Wallace Pharmaceuticals Pvt. Ltd. | Disposed |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Wallace Pharmaceuticals Pvt. Ltd. | Disposed |
To see the full case history of Prism Pharma (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prism Pharma (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Prism Pharma (India) has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECA9288R1ZU | Tamil Nadu | Active | 01 Jul 2017 |
| 37AAECA9288R1ZM | Andhra Pradesh | Active | 22 May 2019 |
To see the full GST registrations and return filing status of Prism Pharma (India) Private Limited, buy the company report.
Recent activity
Prism Pharma (India) Private Limited has 4 board changes on record since 2002: 2 appointments and 2 cessations. The latest: Ramalingam Jayaram ceased to be Additional Director on 30 Sep 2018.
AGM
Prism Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 29.20 Lakh registered on 09 Aug 2004 with Charge ID 90286152 was modified on 02 Aug 2025.
Filing
Prism Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.00 Lakh with Charge ID 100692110 was registered on 12 Dec 2022.
Charges
A charge with State Bank Of India amounted to Rs. 5.88 Lakh with Charge ID 100376482 was registered on 16 Sep 2020.
Ceased
Ramalingam Jayaram ceased to be Additional Director.
Ceased
Ganapathi Mahesh Babu ceased to be Director.
Appointed
Ramalingam Jayaram was appointed as Director.
Charges
A charge registered on 07 Oct 2005 via Charge ID 90289676 with Sundaram Finance Limited was fully satisfied on 12 Jul 2011.
Charges
A charge with State Bank Of India of Rs. 101.45 Lakh registered on 09 Aug 2004 with Charge ID 90302912 was modified on 11 May 2011.
Charges
A charge with Sundaram Finance Limited amounted to Rs. 2.42 Lakh with Charge ID 90289676 was registered on 07 Oct 2005.
Charges
A charge with State Bank Of India amounted to Rs. 101.45 Lakh with Charge ID 90302912 was registered on 09 Aug 2004.
3 earlier events are in the company report.
Frequently asked questions
Prism Pharma (India) is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 September 2002 (24+ years old) and is registered under CIN U24231TN2002PTC049597.
Prism Pharma (India) has 2 current directors:
- Ramalingam Lakshmi - Director
- Ramalingam Jayaram - Director
The latest financial statements of Prism Pharma (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Prism Pharma (India) is 33AAECA9288R1ZU, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAECA9288R1ZM (Andhra Pradesh).
The CIN (Corporate Identification Number) of Prism Pharma (India) is U24231TN2002PTC049597. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prism Pharma (India) has 3 court cases on record: 3 filed against it.
Prism Pharma (India) was incorporated on 13 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Prism Pharma (India) by revenue are Ambrosia Remedies Pvt Ltd, Kalpasthana Life Care Products Private Limited, Cureford Healthcare Private Limited, Vibrant Pharmacuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramalingam Jayaram ceased to be Additional Director on 30 Sep 2018. Ganapathi Mahesh Babu ceased to be Director on 21 Sep 2017. Ramalingam Jayaram was appointed as Director on 21 Sep 2017. Prism Pharma (India) has 4 board changes on record in total.
Yes, Prism Pharma (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-24-0029163).
The registered office of Prism Pharma (India) is at 12573 Golden Colonymogappair Chennai 600 050, Tamil Nadu, India – 600050.